Immunoregulation in the gut: Success and failures in human disease

Gut

Volumn 50, Issue SUPPL. 3, 2002, Pages

  Monteleone, I ^a   Vavassori, P ^a   Biancone, L ^a   Monteleone, G ^a   Pallone, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; GAMMA INTERFERON; INTERLEUKIN 12;

CONFERENCE PAPER; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INTESTINE; INTESTINE MUCOSA; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; ULCERATIVE COLITIS;

EID: 0036107919     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.suppl_3.iii60     Document Type: Conference Paper

References (54)

1. Lamina propria T cells
2. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
3. Interleukin 12 and Th1 responses in inflammatory bowel disease
4. Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile
5. Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue
6. Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes
7. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis
8. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation
9. T cell immunity to oral allergens
10. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
11. Inflammatory bowel disease: Etiology and pathogenesis
12. Recent developments in the immunology of inflammatory bowel disease
13. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens
14. Crohn's disease stable remission after human immunodeficiency virus infection
15. Treatment of murine colitis by lactococcus lactis secreting interleukin-10
16. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGFβ1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain down-regulation
17. Blocking Smad7 restores TGF-betal signaling in chronic inflammatory bowel disease
18. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis
19. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance
20. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn's disease and experimental colitis in vivo
21. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
22. IL-6 is required for the development of Th1 cell-mediated murine colitis
23. Ib-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production
24. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers
25. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease
26. Functional diversity of helper T lymphocytes
27. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
28. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease
29. Up-regulation of the IL-12 receptor ?2 chain in Crohn's disease
30. Response of human intestinal lamina propria T lymphocytes to interleukin 12: Additive effects of interleukin 15 and 7
31. Bioactive interleukin-18 expression is up-regulated in Crohn's disease
32. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner
33. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease
34. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells
35. Chronic intestinal inflammation in STAT-4 transgenic mice: Characterization of disease and adoptive transfer by TNF-plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens
36. Antibodies to IL-12 abrogate established experimental colitis in mice
37. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon
38. Neutrophil cytoplasmic antibodies: A link between sclerosing cholangitis and ulcerative colitis
39. Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis
40. Autoimmunity in ulcerative colitis (UC): A predominant colonic mucosal B cell response against human tropomyosin isoform 5
41. Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 KD putative autoantigen in ulcerative colitis
42. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody
43. Tumour necrosis factor and Crohn's disease
44. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice
45. Role of NF-kB in immune and inflammatory responses in the gut
46. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
47. T cells orchestrate intestinal mucosal shape and integrity
48. A major role for matrix metalloproteinases in T cell injury in the gut
49. Enhancing lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury
50. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinose production
51. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease
52. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease
53. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers
54. Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia